Elogium Probiotics
PrivateLast Round
Grant
Jun 26, 2025
Total Funding Raised
$594,000
Company Overview
Elogium Probiotics operates in Healthcare & Life Sciences and is based in Riga. Its latest recorded funding round was a Seed round in February 2023.
Elogium Probiotics is a biotechnology company that develops a probiotic feed additive for the poultry industry designed to combat pathogens and improve growth.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Compliance
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elogium Probiotics Comparables
Compare Elogium Probiotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Akeso Biomedical, Inc. | 82% | |
| General Probiotics | 78% | |
| Proteon Pharmaceuticals | 78% |
For institutional investors. Book with your work email.
Elogium Probiotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 26, 2025 | ||||
| Seed | Feb 16, 2023 | ||||
| Pre Seed | Sep 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Elogium Probiotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotope by VIB | Seed, Pre Seed |
| European Regional Development Fund | Grant |
| SIA “Farmācijas, biomedicīnas un medicīnas tehnoloģiju Kompetences centrs” | Grant |
| Commercialization Reactor | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 107% MoM, reaching 2.3K.
- May 16, 2026
Monthly visitors increased 34% MoM.
For institutional investors. Book with your work email.
Elogium Probiotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elogium Probiotics's valuation, stock price, and market status.
Is Elogium Probiotics a public or private company?
Elogium Probiotics is a private company.
What is the current stock price of Elogium Probiotics?
Elogium Probiotics is a private company, so its shares have no public market price. Caplight tracks Elogium Probiotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elogium Probiotics worth (valuation)?
Valuation information for Elogium Probiotics is not publicly available.
Can I buy Elogium Probiotics stock?
Elogium Probiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elogium Probiotics's last funding round?
Elogium Probiotics's most recent funding round was Grant on June 26, 2025.
Who are the main investors in Elogium Probiotics?
Key investors in Elogium Probiotics include Commercialization Reactor.
Will Elogium Probiotics IPO soon?
No public IPO plans have been announced for Elogium Probiotics.
How can I track Elogium Probiotics secondary market activity?
Caplight tracks bids, offers, and trades in Elogium Probiotics's shares on secondary markets.